AstraZeneca

The remarkable global effort to produce a range of Covid-19 vaccines in parallel with developing new treatments – many of which are adapting proven me(...)

A coronavirus vaccine from Germany’s BioNTech has yielded positive trial results, generating immune defences in participants that were stronger than t(...)

French drugmaker Sanofi said on Tuesday it expects to get approval for the potential Covid-19 vaccine it is developing with Britain’s GlaxoSmithKline (...)

European shares closed lower on Thursday as a spike in Covid-19 cases in China and some US states triggered fears of a second wave of infections. And (...)

The European Union has laid out plans to place advance orders for coronavirus vaccines currently under development to ensure supplies for member state(...)

European shares pulled back from three-month highs on Monday, with losses in technology and healthcare stocks halting a recent rally on hopes of a pos(...)

European shares retreated from three-month highs on Monday, as investors locked in some profits following a strong rally last week on hopes of a post-(...)

Shares of Gilead Sciences rose as much as 3 per cent on Monday after a report said the US drugmaker had been approached by Britain’s AstraZeneca for (...)

British drugmaker AstraZeneca has doubled manufacturing capacity for its potential coronavirus vaccine to two billion doses in two deals involving Mic(...)

European shares rose for a fourth straight session on Thursday, as optimism over businesses returning to work and stimulus for the battered euro-zone (...)